NO2021022I1 - Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein - Google Patents

Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein

Info

Publication number
NO2021022I1
NO2021022I1 NO2021022C NO2021022C NO2021022I1 NO 2021022 I1 NO2021022 I1 NO 2021022I1 NO 2021022 C NO2021022 C NO 2021022C NO 2021022 C NO2021022 C NO 2021022C NO 2021022 I1 NO2021022 I1 NO 2021022I1
Authority
NO
Norway
Prior art keywords
carrier protein
neisseria meningitidis
tetanus toxoid
polysaccharide conjugated
meningitidis group
Prior art date
Application number
NO2021022C
Other languages
English (en)
Norwegian (no)
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2006/006268 external-priority patent/WO2007000341A2/en
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of NO2021022I1 publication Critical patent/NO2021022I1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO2021022C 2005-06-27 2021-05-25 Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein NO2021022I1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
PCT/EP2006/006268 WO2007000341A2 (en) 2005-06-27 2006-06-23 Immunogenic composition
NO20076343A NO345422B1 (no) 2005-06-27 2006-06-23 Immunogent preparat, vaksine omfattende immunogent preparat, fremgangsmåte for fremstilling av vaksinen og anvendelse av immunogent preparat for behandling eller forebygging av sykdom.

Publications (1)

Publication Number Publication Date
NO2021022I1 true NO2021022I1 (no) 2021-05-25

Family

ID=34856207

Family Applications (2)

Application Number Title Priority Date Filing Date
NO2021022C NO2021022I1 (no) 2005-06-27 2021-05-25 Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein
NO2025018C NO2025018I1 (no) 2005-06-27 2025-04-08 Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein - forlengelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2025018C NO2025018I1 (no) 2005-06-27 2025-04-08 Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein - forlengelse

Country Status (8)

Country Link
CN (4) CN101247827B (enExample)
BE (1) BE2021C560I2 (enExample)
ES (1) ES2367918T5 (enExample)
FR (1) FR12C0060I2 (enExample)
GB (1) GB0513069D0 (enExample)
NO (2) NO2021022I1 (enExample)
UA (1) UA97233C2 (enExample)
ZA (3) ZA200710853B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE040914T4 (hu) * 2012-01-30 2019-05-28 Serum Institute Of India Pvt Ltd Immunogén készítmény
HUE049531T2 (hu) * 2012-08-16 2020-10-28 Pfizer Glikokonjugációs eljárások és kompozíciók
AU2017321863B2 (en) * 2016-09-02 2024-07-11 Sanofi Vaccines US Inc. Neisseria meningitidis vaccine
LT3544637T (lt) * 2016-11-25 2021-03-25 Glaxosmithkline Biologicals S.A. Natyvių omv ir antigeno konjugatai bei jų naudojimo būdas
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
WO2021099982A1 (en) * 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
CN115819616B (zh) * 2021-07-28 2025-04-11 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
CN115721709A (zh) * 2021-08-27 2023-03-03 康希诺生物股份公司 一种肺炎球菌结合疫苗制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
OA12302A (en) * 2000-06-29 2003-10-24 Glaxosmithkline Biolog Sa Multivalent vaccine composition.
EP1372707A1 (en) * 2001-04-06 2004-01-02 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖－蛋白结合疫苗
DK1587537T3 (da) * 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper

Also Published As

Publication number Publication date
GB0513069D0 (en) 2005-08-03
CN101247827B (zh) 2013-07-17
CN101208101A (zh) 2008-06-25
CN101222935A (zh) 2008-07-16
FR12C0060I2 (fr) 2017-01-06
CN101222935B (zh) 2015-07-29
CN101208103A (zh) 2008-06-25
CN101208101B (zh) 2013-01-02
ES2367918T5 (es) 2014-11-21
CN101208103B (zh) 2013-04-24
NO2025018I1 (no) 2025-04-08
UA97233C2 (uk) 2012-01-25
ZA200711074B (en) 2009-07-29
ZA200710853B (en) 2009-04-29
CN101247827A (zh) 2008-08-20
FR12C0060I1 (enExample) 2012-12-14
BE2021C560I2 (enExample) 2026-02-02
ZA200710909B (en) 2009-04-29
ES2367918T3 (es) 2011-11-10

Similar Documents

Publication Publication Date Title
NL301151I2 (nl) Neisseria meningitidis-groep A polysaccharide, Neisseria meningitidis-groep C polysaccharide, Neisseria meningitidis-groep W-135 polysaccharide, Neisseria meningitidis-groep Y polysaccharide, geconjugeerd aan tetanustoxoïddragereiwit
NO2021022I1 (no) Neisseria meningitidis group A polysaccharide conjugated to a tetanus toxoid carrier protein
DK1973564T3 (da) Vaccine omfattende streptococcus pneumoniae-kapselpolysaccharidkonjugat
ATE548051T1 (de) Multivalente pneumokokken- polysaccharidproteinkonjugatzusammensetzung
EG25398A (en) Modified christmas tree components and associated methods for using coiled tubing in a well.
LT1824988T (lt) Nukreipta į užduotą saitą fviii modifikacija
FR2890288B1 (fr) Bracelet repulsif antimoustique a base de produits naturels
EP1908819A4 (en) MICROORGANISM PRODUCED BY A BIFIDOBACTERIUM GENERATED POLYSACCHARIDE
EP1963522A4 (en) MULTIVALENT MENINGOCOCCAL DERIVATIVE POLYSACCHARIDE-PROTEIN CONJUGATES AND VACCINE
FIC20210047I1 (fi) Neisseria meningitidis ryhmä A polysakkaridi, Neisseria meningitidis ryhmä C polysakkaridi, Neisseria meningitidis ryhmä W-135 polysakkaridi, Neisseria meningitidis ryhmä Y polysakkaridi, kukin konjugoituina tetanustoksoidikantajaproteiiniin
FR2906441B1 (fr) Repulsif insectes a base de molecules naturelles.
PL372503A1 (pl) Moduł złączny choinki
NO20050709D0 (no) Anordning for a forbinde et ventiltre med et bronnhode, ventiltre og en fremgangsmate for a forbinde et ventiltre med et bronnhode
FIU20050076U0 (fi) Sovitelma imurilaitteistossa
ZA200805347B (en) Pneumococcal polysaccharide conjugate vaccine
SE0402411L (sv) Julgransfot
FI20065043A0 (fi) Järjestely maatilan tuotantorakennuksessa
GB0526633D0 (en) Christmas tree tidy
SK4395U (sk) Podstavec pre prstencový vianočný stromček
ITBG20060014U1 (it) Metodo imbottitura per cuscini decorativi da collezione
TH89100B (th) เตียง
TH89101B (th) เตียง
ES1065317Y (es) Arbol de navidad iluminado
PL115309U1 (en) Christmas tree stand
HK1122502A (en) Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates